MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-09-0014941
Millennial Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.94 Cr
▲ 39% YoY
Net profit · FY 2025
₹8.61 Lakh
Net margin 4.4%
EBITDA · FY 2025
₹13.07 Lakh
EBITDA margin 6.7%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Millennial Pharmaceuticals Private Limited
Data last updated:
Millennial Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51900TG2020PTC140019. Its GSTIN is 36AANCM4029K1Z4 (Telangana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shaik Ismail Saheb and Syed Ghouse.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.94 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹8.61 Lakh (net margin 4.4%) and EBITDA of ₹13.07 Lakh (EBITDA margin 6.7%). Revenue has grown at a compounded annual rate (CAGR) of 48% over three years.
Millennial Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0014941). For more details, the company can be reached via its website sismillennialpharma.com.
Company details
CIN U51900TG2020PTC140019
Registration Number 140019
Incorporation Date 31 March 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0014941
Recognitions & Rankings of Millennial Pharmaceuticals
Contact details
Millennial Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is sismillennialpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No 3 – 67/3/536 Ground Floor, Shop No .01 & 02 Nallagandla Serlingampally, Hyderabad, Telangana, India – 500019
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Millennial Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Millennial Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Millennial Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Millennial Pharmaceuticals Private Limited, buy the company report.
Financials of Millennial Pharmaceuticals Private Limited
FY 2025 filings availableMillennial Pharmaceuticals Private Limited reported revenue of ₹1.94 Cr (up 39% YoY) for FY 2025.
Revenue · FY 2025
₹1.94 Cr ▲ 39%
Net profit · FY 2025
₹8.61 Lakh margin 4.4%
EBITDA · FY 2025
₹13.07 Lakh margin 6.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 48%
EBITDA CAGR growth
1 year
▲ 51%
3 years · compounded
▲ 78%
Revenue has grown at a compounded annual rate (CAGR) of 48% over three years, including 39% growth in the latest year. EBITDA rose 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.61 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.7% | ||||
| Net Profit Margin | 4.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Millennial Pharmaceuticals Private Limited, buy the company report.
Board of directors of Millennial Pharmaceuticals Private Limited
Millennial Pharmaceuticals has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shaik Ismail Saheb Also directs: Centennial Pharmaceuticals Private Limited | Director | 13 Feb 2023 | 3 Years 8 Months | Current |
| Syed Ghouse | Additional Director | 28 Jan 2026 | 0 Years 9 Months | Current |
Peer comparison
Millennial Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shivaxy Pharmaceuticals Private Limited | ₹1.97 Cr (FY 2025) | -32.0% | Bangalore, Karnataka, India | |||
| Tapashi Pharmaceuticals Private Limited | ₹1.95 Cr (FY 2025) | -66.0% | Vadodara, Gujarat, India | |||
| Millennial Pharmaceuticals Private Limitedthis company | ₹1.94 Cr (FY 2025) | ₹8.61 Lakh | 4.4% | 39.0% | Hyderabad, Telangana, India | |
| Laurel Pharmaceuticals Pvt Ltd | ₹1.91 Cr (FY 2025) | -7.0% | Jalandhar, Punjab, India |
To see the full peer comparison of Millennial Pharmaceuticals Private Limited, buy the company report.
Auditor
Millennial Pharmaceuticals Private Limited is audited by GVR&CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GVR&CO | FY 2023 | 013715S |
Shareholding
The shareholding of Millennial Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Millennial Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Millennial Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Millennial Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Millennial Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 02, 2024.
Active EPFO establishments
1
GST
Millennial Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AANCM4029K1Z4 | Telangana | Active | 07 Apr 2020 |
To see the full GST registrations and return filing status of Millennial Pharmaceuticals Private Limited, buy the company report.
Recent activity
Millennial Pharmaceuticals Private Limited has 11 board changes on record since 2021: 3 appointments and 8 cessations. The latest: Syed Ghouse was appointed as Additional Director on 28 Jan 2026.
Appointed
Syed Ghouse was appointed as Additional Director.
AGM
Millennial Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Millennial Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Syed Ghouse ceased to be Director.
Appointed
Zahera Banu was appointed as Director.
Ceased
Shaik Mahaboob Basha ceased to be Additional Director.
Ceased
Molla Mahammad Rafi ceased to be Director.
Ceased
Vamsi Kumar Gunda ceased to be Director.
Ceased
Magbul Basha Syed ceased to be Additional Director.
Ceased
Zahera Banu ceased to be Additional Director.
Appointed
Shaik Ismail Saheb was appointed as Director.
Ceased
Shaik Ismail Saheb ceased to be Director.
2 earlier events are in the company report.
Frequently asked questions
Millennial Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 March 2020 (6+ years old) and is registered under CIN U51900TG2020PTC140019.
Millennial Pharmaceuticals has 2 current directors:
- Shaik Ismail Saheb - Director
- Syed Ghouse - Additional Director
The latest financial statements of Millennial Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Millennial Pharmaceuticals is 36AANCM4029K1Z4, registered in Telangana.
The CIN (Corporate Identification Number) of Millennial Pharmaceuticals is U51900TG2020PTC140019. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Millennial Pharmaceuticals was incorporated on 31 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Millennial Pharmaceuticals by revenue are Shivaxy Pharmaceuticals Private Limited, Tapashi Pharmaceuticals Private Limited, Laurel Pharmaceuticals Pvt Ltd, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Syed Ghouse was appointed as Additional Director on 28 Jan 2026. Syed Ghouse ceased to be Director on 15 Oct 2024. Zahera Banu was appointed as Director on 15 Oct 2024. Millennial Pharmaceuticals has 11 board changes on record in total.
Yes, Millennial Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0014941).
Millennial Pharmaceuticals can be reached through the website sismillennialpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Millennial Pharmaceuticals is at H.No 3 – 673536 Ground Floor, Shop No .01 & 02 Nallagandla Serlingampally, Hyderabad, Telangana, India – 500019.